TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial
Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.
Cardiologists develop new AI screening tool for structural heart disease
Researchers have developed an advanced AI model capable of detecting signs of severe AS, mitral regurgitation and other complications in ECG results. For example, one 84-year-old patient who was hospitalized for a fractured femur ended up being scanned and treated with TAVR just days later.
World’s first polymeric TAVR valve impresses cardiologists—could improve durability, reduce costs
The new-look TAVR system was linked to multiple benefits after one year. The cardiologists evaluating this device belief it could significantly reduce the risk of long-term valve degeneration.
Cardiologists perform first TAVR of its kind by anchoring valve to crushed stent
The patient, 78, presented with severe AR and no signs of calcification. She was considered a poor choice for surgery or traditional TAVR due to multiple risks. That is where the new-look ATLAS technique came in.
3D software helps cardiologists plan ahead for TAVR complications
Serious complications are rare after TAVR, but they can be catastrophic or fatal when they do occur. The care team at Sentara Heart Hospital found that bringing in new 3D software made it much easier to plan ahead for such issues.

SCAI 2021: 98% of new TAVR programs developed in metropolitan areas

Researchers tracked 554 TAVR programs that opened from 2012 to 2018, sharing their findings at the SCAI 2021 Scientific Sessions.

Surgical risk scores may not be needed when considering TAVR

Recent TAVR research suggests clinicians should focus on other key factors such as the patient's age and life expectancy.

Risk of death, stroke increases with age for TAVR patients

The risk of post-TAVR pacemaker implantation also goes up when treating elderly patients.

COVID-19 patients undergoing TAVR may face a higher risk of death

The study included data from more than 3,000 TAVR patients who received care from January 2020 to January 2021.

Specialists complete first procedure in historic head-to-head TAVR study

The global trial is designed to compare TAVR systems from Medtronic and Edwards Lifesciences when treating patients with small annuli.

What TAVR availability has meant for patients with severe aortic stenosis

The impact on patients over the age of 65 has been undeniable.

How heart rhythm issues affect 2-year TAVR, SAVR outcomes

The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.

Researchers examine ‘concerning’ out-of-hospital 30-day mortality rate for TAVR patients

Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018.

TAVR

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Cardiologists develop new AI screening tool for structural heart disease

World’s first polymeric TAVR valve impresses cardiologists—could improve durability, reduce costs

Cardiologists perform first TAVR of its kind by anchoring valve to crushed stent

3D software helps cardiologists plan ahead for TAVR complications